Arch Therapeutics, Inc. Quarterly Earnings Per Share, Diluted in USD/shares from Q2 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
Arch Therapeutics, Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from Q2 2013 to Q2 2024.
  • Arch Therapeutics, Inc. Earnings Per Share, Diluted for the quarter ending June 30, 2024 was -1.44 USD/shares, a 1.41% decline year-over-year.
  • Arch Therapeutics, Inc. annual Earnings Per Share, Diluted for 2021 was -0.03 USD/shares, a 50% decline from 2020.
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$1 $0 -1.41% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q2 2023 -$1 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2020 $0 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-05
Q1 2019 $0 +$0.01 Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 $0 $0 Oct 1, 2018 Dec 31, 2018 10-Q 2019-02-01
Q1 2018 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 $0 +$0.01 Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-01
Q4 2016 $0 $0 0% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-01
Q4 2015 $0 $0 -200% Oct 1, 2015 Dec 31, 2015 10-Q 2016-02-12
Q2 2015 $0 $0 -300% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-07
Q4 2014 $0.01 +$0.02 Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-12
Q2 2014 $0.01 +$0.07 Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q4 2013 $0 Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-09
Q2 2013 $0 Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.